STAND NR. 12

For over a quarter of a century, our customers have entrusted us with their products. It’s a responsibility we’ve always cherished — consistently upholding the highest standards of both quality and service to ensure your next project is delivered on time and in full.

Our company began its journey back in 1995 with the management buyout of a solid dose facility in Stockholm, including a portfolio of around 20 well-known pharmaceutical products.

Over the years, Recipharm has continued to grow organically and through the acquisition of 30 + facilities to become the fourth largest global CDMO.

In March 2021, Recipharm AB was delisted from the stock exchange and became a private company owned by private equity firm EQT IX.